Hanmi grew 33.4 percent in September

The value by Hanmi Pharm in the outpatient prescription sector in September grew 33.4 percent, to 18.7 billion won, compared with the same month of last year, due to strong demand of its first generic version of Norvask plus Amaryl generic, a local report said recently.

The combined prescription amount of pharmaceutical firms for outpatients totaled 383.5 billion won in September, showing a ...